Bausch Health Companies Inc. Earnings Per Share, Basic and Diluted
Bausch Health Companies Inc. (BHC) reported Earnings Per Share, Basic and Diluted of -$0.43 per share for the 3-month period ending 2020-12-31, per its 8-K filed 2021-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-04
- Bausch Health Companies Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.43.
- Bausch Health Companies Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was $0.20.
- Bausch Health Companies Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.92.
- Bausch Health Companies Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.43.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$0.43 8-K · filed 2021-05-04 | -$1.58 8-K · filed 2021-05-04 | ||
| 2020-09-30 | $0.20 8-K · filed 2021-05-04 | |||
| 2020-06-30 | -$0.92 8-K · filed 2021-05-04 | -$1.35 10-Q · filed 2020-08-06 | -$5.64 derived: net income ÷ weighted average shares · filed 2021-05-04 | -$5.78 derived: net income ÷ weighted average shares · filed 2021-05-04 |
| 2020-03-31 | -$0.43 8-K · filed 2021-05-04 | -$4.72 derived: net income ÷ weighted average shares · filed 2021-05-04 | -$4.87 derived: net income ÷ weighted average shares · filed 2021-05-04 | -$5.35 derived: net income ÷ weighted average shares · filed 2021-05-04 |
| 2019-12-31 | -$4.30 8-K · filed 2021-05-04 | -$4.44 derived: net income ÷ weighted average shares · filed 2021-05-04 | -$4.93 derived: net income ÷ weighted average shares · filed 2021-05-04 | -$5.08 8-K · filed 2021-05-04 |
| 2019-09-30 | -$0.14 8-K · filed 2021-05-04 | -$0.62 derived: net income ÷ weighted average shares · filed 2021-05-04 | -$0.77 10-Q · filed 2019-11-04 | -$1.75 derived: net income ÷ weighted average shares · filed 2021-05-04 |
| 2019-06-30 | -$0.49 8-K · filed 2021-05-04 | -$0.63 10-Q · filed 2020-08-06 | -$1.61 derived: net income ÷ weighted average shares · filed 2021-05-04 | -$2.61 derived: net income ÷ weighted average shares · filed 2021-05-04 |
| 2019-03-31 | -$0.15 8-K · filed 2021-05-04 | -$1.13 derived: net income ÷ weighted average shares · filed 2021-05-04 | -$2.12 derived: net income ÷ weighted average shares · filed 2021-05-04 | -$4.61 derived: net income ÷ weighted average shares · filed 2021-05-04 |
| 2018-12-31 | -$0.98 10-K · filed 2020-02-19 | -$1.97 derived: net income ÷ weighted average shares · filed 2021-05-04 | -$4.46 derived: net income ÷ weighted average shares · filed 2021-05-04 | -$11.81 8-K · filed 2021-05-04 |
| 2018-09-30 | -$1.00 10-K · filed 2020-02-19 | -$3.48 derived: net income ÷ weighted average shares · filed 2020-02-19 | -$10.83 10-Q · filed 2019-11-04 | |
| 2018-06-30 | -$2.49 10-K · filed 2020-02-19 | -$9.84 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | -$7.36 10-K · filed 2020-02-19 | |||
| 2014-03-31 | -$0.07 10-Q · filed 2014-05-09 | |||
| 2013-03-31 | -$0.09 10-Q · filed 2014-05-09 | |||
| 2012-03-31 | -$0.04 10-Q · filed 2013-05-03 | |||
| 2011-03-31 | $0.02 10-Q · filed 2012-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |